scispace - formally typeset
G

Gu He

Researcher at Sichuan University

Publications -  150
Citations -  9315

Gu He is an academic researcher from Sichuan University. The author has contributed to research in topics: Enantioselective synthesis & Chemistry. The author has an hindex of 30, co-authored 134 publications receiving 7695 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles.

TL;DR: It is speculated that PLGANPs simultaneously loaded with anticancer drug and chemosensitizer might be the most potential formulation in the treatment of drug resistant cancers in vivo.
Journal ArticleDOI

Asymmetric organocatalysis: an enabling technology for medicinal chemistry

TL;DR: A comprehensive overview of the applications of asymmetric organocatalysis in medicinal chemistry can be found in this article, with a focus on the preparation of antiviral, anticancer, neuroprotective, cardiovascular, antibacterial, and antiparasitic agents, as well as several miscellaneous bioactive agents.
Journal ArticleDOI

Protein SUMOylation modification and its associations with disease

TL;DR: The signal crosstalk between SUMOylation and ubiquitination of proteins, protein SUMOolation relations with several diseases, and the identification approaches for SUMOYLation site are discussed.
Journal ArticleDOI

Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy.

TL;DR: This review comprehensively focuses on summarizing 12 cell death subroutines and discussing their corresponding small‐molecule compounds in potential cancer therapy, to provide more evidence to fill in the gaps between cell deathSubroutine and small-molecular compounds to better develop novel cancer therapeutic strategies.